Hospital
Forsyth Memorial Hospital, INC.
Forsyth Memorial Hospital, INC. was paid $40.94M by Medicaid between Jan 2018 and Dec 2024, across 182 billing codes. Its largest line is 99284, emergency room visit (serious) — 31% of everything it billed.
33Billing provider infoFORSYTH MEMORIAL HOSPITAL, INC.
WINSTON SALEM, NC 27103
WINSTON SALEM, NC 27103
33aNPI1447200233assigned 05/11/2006
33bProvider typeGeneral Acute Care Hospital
28Total paid$40.94M
24GClaims1,172,485
24DCodes billed182
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other General Acute Care Hospital providers in North Carolina
Rank by total paid#13 of 92
Median peer was paid$11.47M
This provider vs. median3.6×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 134,257 | $3.60M | |
| 2019 | 150,559 | $3.92M | |
| 2020 | 127,577 | $3.55M | |
| 2021 | 178,005 | $5.75M | |
| 2022 | 168,646 | $7.07M | |
| 2023 | 214,006 | $8.11M | |
| 2024incomplete | 199,435 | $8.95M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 31% | 67,888 | 61,838 | $12.56M |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 17% | 69,872 | 64,533 | $7.00M |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 12% | 21,506 | 19,561 | $4.81M |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | 4.9% | 14,359 | 13,229 | $2.00M |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 4.6% | 3,405 | 3,140 | $1.87M |
| 70450 | Computed tomography, head or brain; without contrast material | 2.8% | 8,869 | 8,184 | $1.13M |
| 96375 | Therapeutic injection; each additional sequential IV push | 2.6% | 19,991 | 17,897 | $1.06M |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 2.4% | 31,919 | 29,322 | $986K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 2.3% | 38,151 | 33,753 | $925K |
| 80053 | Comprehensive metabolic panel | 2.0% | 102,261 | 89,730 | $820K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 2.0% | 117,534 | 101,235 | $819K |
| 96361 | Intravenous infusion, hydration; each additional hour | 1.9% | 18,395 | 16,515 | $768K |
170 more codes
| 71045 | Radiologic examination, chest; single view | 1.8% | 22,521 | $756K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 1.8% | 11,996 | $747K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 8,794 | $408K |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 15,561 | $365K |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | <1% | 61,290 | $320K |
| J3490 | Unclassified drugs | <1% | 239,582 | $286K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 6,836 | $277K |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 14,450 | $200K |
| 83735 | <1% | 24,837 | $145K | |
| 81025 | <1% | 18,552 | $139K | |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | <1% | 4,956 | $137K |
| 84484 | <1% | 12,673 | $132K | |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 31,422 | $111K |
| 83690 | <1% | 15,733 | $108K | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 4,993 | $106K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 8,125 | $103K |
| 81001 | <1% | 33,046 | $101K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 11,083 | $91K |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 12,726 | $82K |
| D0220 | Intraoral - periapical first radiographic image | <1% | 1,199 | $72K |
| 80299 | <1% | 4,949 | $71K | |
| D0230 | Intraoral - periapical each additional radiographic image | <1% | 1,133 | $68K |
| H0015 | Alcohol and/or drug services; intensive outpatient (treatment program that operates at least 3 hours/day and at least 3 days/week and is based on an individualized treatment plan), including assessment, counseling; crisis intervention, and activity therapies or education | <1% | 1,016 | $67K |
| 76816 | Ultrasound, pregnant uterus, real time with image documentation, follow-up | <1% | 1,698 | $56K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | <1% | 156 | $55K |
| 90853 | Group psychotherapy (other than of a multiple-family group) | <1% | 1,550 | $54K |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 3,240 | $49K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 2,733 | $47K |
| 76811 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed | <1% | 750 | $47K |
| 72125 | Computed tomography, cervical spine; without contrast material | <1% | 153 | $46K |
| G0177 | Training and educational services related to the care and treatment of patient's disabling mental health problems per session (45 minutes or more) | <1% | 2,344 | $44K |
| D1208 | Topical application of fluoride, excluding varnish | <1% | 728 | $39K |
| 71275 | Computed tomographic angiography, chest, with contrast material | <1% | 71 | $35K |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | <1% | 779 | $35K |
| T1023 | Screening to determine the appropriateness of consideration of an individual for participation in a specified program, project or treatment protocol, per encounter | <1% | 412 | $35K |
| D2930 | Prefabricated stainless steel crown - primary tooth | <1% | 302 | $34K |
| 90791 | Psychiatric diagnostic evaluation | <1% | 367 | $31K |
| U0004 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r | <1% | 450 | $29K |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 1,841 | $27K |
| 81003 | <1% | 12,398 | $27K | |
| 84703 | <1% | 2,465 | $26K | |
| D1120 | Dental cleaning, child | <1% | 495 | $25K |
| 76819 | Fetal biophysical profile; without non-stress testing | <1% | 735 | $24K |
| 87631 | <1% | 254 | $22K | |
| J2704 | Injection, propofol, 10 mg | <1% | 1,395 | $22K |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 908 | $21K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | <1% | 1,733 | $20K |
| 76820 | <1% | 715 | $19K | |
| D3220 | Therapeutic pulpotomy (excluding final restoration) - removal of pulp coronal to the dentinocemental junction | <1% | 157 | $19K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 357 | $18K |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 2,885 | $17K |
| 80143 | <1% | 1,097 | $17K | |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | <1% | 1,232 | $15K |
| 80179 | <1% | 1,113 | $15K | |
| D2392 | Resin-based composite - two surfaces, posterior, primary or permanent | <1% | 257 | $14K |
| 87637 | Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV | <1% | 133 | $14K |
| 85730 | <1% | 3,034 | $13K | |
| 92650 | <1% | 250 | $13K | |
| 76815 | Ultrasound, pregnant uterus, real time with image documentation, limited | <1% | 493 | $13K |
| 85610 | <1% | 4,557 | $13K | |
| J1030 | Injection, methylprednisolone acetate, 40 mg | <1% | 553 | $11K |
| 96413 | Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance | <1% | 344 | $11K |
| J0665 | Injection, bupivicaine, not otherwise specified, 0.5 mg | <1% | 591 | $11K |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | <1% | 467 | $10K |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 164 | $9K |
| G0378 | Hospital observation service, per hour | <1% | 133 | $8K |
| J7120 | Ringers lactate infusion, up to 1000 cc | <1% | 2,341 | $8K |
| D2391 | Resin-based composite - one surface, posterior, primary or permanent | <1% | 148 | $8K |
| 0202U | Oncology (prostate), multianalyte, gene expression profiling | <1% | 15 | $8K |
| 97161 | <1% | 163 | $7K | |
| 36415 | Collection of venous blood by venipuncture | <1% | 6,165 | $7K |
| J1170 | Injection, hydromorphone, up to 4 mg | <1% | 302 | $7K |
| D7140 | Extraction, erupted tooth or exposed root | <1% | 122 | $7K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 128 | $7K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 804 | $6K |
| 82550 | <1% | 1,171 | $6K | |
| 76801 | <1% | 85 | $5K | |
| D1351 | Sealant - per tooth | <1% | 99 | $5K |
| J1010 | Injection, methylprednisolone acetate, 1 mg | <1% | 181 | $5K |
| 83880 | <1% | 153 | $4K | |
| 76818 | <1% | 114 | $4K | |
| J7050 | Infusion, normal saline solution, 250 cc | <1% | 1,860 | $4K |
| 84145 | <1% | 178 | $4K | |
| 85027 | <1% | 859 | $4K | |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | <1% | 58 | $4K |
| 85379 | <1% | 330 | $3K | |
| 84702 | <1% | 293 | $3K | |
| 83605 | <1% | 262 | $3K | |
| 80061 | Lipid panel | <1% | 913 | $3K |
| 93296 | <1% | 1,225 | $3K | |
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | <1% | 15 | $3K |
| 87430 | <1% | 201 | $3K | |
| 82728 | <1% | 288 | $3K | |
| 96376 | <1% | 110 | $3K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 91 | $2K |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | <1% | 47 | $2K |
| 87070 | <1% | 240 | $2K | |
| V2632 | Posterior chamber intraocular lens | <1% | 74 | $2K |
| 36591 | <1% | 172 | $2K | |
| 87210 | <1% | 439 | $2K | |
| 99213 | Doctor's office visit, returning patient (routine) | <1% | 191 | $2K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 50 | $2K |
| 97112 | Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination | <1% | 82 | $2K |
| 80306 | <1% | 138 | $2K | |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | <1% | 50 | $2K |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 97 | $2K |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 146 | $2K |
| 92586 | <1% | 49 | $2K | |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 18 | $2K |
| 83550 | <1% | 260 | $1K | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 545 | $1K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 58 | $1K |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 954 | $1K |
| 66984 | Extracapsular cataract removal with insertion of intraocular lens prosthesis | <1% | 17 | $1K |
| 83540 | <1% | 260 | $1K | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 46 | $1K |
| 82553 | <1% | 145 | $968.32 | |
| Q3014 | Telehealth originating site facility fee | <1% | 65 | $957.66 |
| 84112 | <1% | 14 | $929.20 | |
| 72100 | <1% | 12 | $858.64 | |
| J8499 | Prescription drug, oral, non chemotherapeutic, nos | <1% | 7,334 | $858.16 |
| J2003 | Injection, lidocaine hydrochloride, 1 mg | <1% | 35 | $847.80 |
| J2060 | Injection, lorazepam, 2 mg | <1% | 106 | $814.23 |
| D1110 | Prophylaxis - adult | <1% | 12 | $813.25 |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | <1% | 32 | $762.94 |
| J2550 | Injection, promethazine hcl, up to 50 mg | <1% | 42 | $602.49 |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 12 | $557.05 |
| 81002 | <1% | 232 | $516.78 | |
| 99199 | Unlisted special service, procedure or report | <1% | 91 | $485.00 |
| 87040 | <1% | 48 | $418.92 | |
| 78452 | Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress | <1% | 110 | $393.53 |
| 80076 | <1% | 63 | $382.21 | |
| 83986 | <1% | 78 | $376.53 | |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | <1% | 52 | $372.62 |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 45 | $366.83 |
| J1790 | Injection, droperidol, up to 5 mg | <1% | 15 | $358.99 |
| Q9969 | Tc-99m from non-highly enriched uranium source, full cost recovery add-on, per study dose | <1% | 86 | $355.35 |
| 51705 | <1% | 44 | $353.48 | |
| 87486 | <1% | 15 | $352.99 | |
| 87581 | <1% | 15 | $352.99 | |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | <1% | 15 | $352.99 |
| 87077 | <1% | 26 | $275.75 | |
| 82570 | <1% | 140 | $275.16 | |
| J0690 | Injection, cefazolin sodium, 500 mg | <1% | 17 | $247.89 |
| 86901 | <1% | 40 | $181.37 | |
| 84156 | <1% | 33 | $163.09 | |
| 83615 | <1% | 18 | $135.10 | |
| 82962 | <1% | 45 | $132.28 | |
| 52000 | <1% | 40 | $120.63 | |
| 97535 | Self-care/home management training, each 15 minutes | <1% | 13 | $120.58 |
| 84550 | <1% | 19 | $106.61 | |
| G0136 | Administration of a standardized, evidence-based assessment of physical activity and nutrition, 5-15 minutes, not more often than every 6 months | <1% | 104 | $95.27 |
| 96127 | <1% | 111 | $92.33 | |
| J0171 | Injection, adrenalin, epinephrine, 0.1 mg | <1% | 59 | $81.84 |
| 99495 | <1% | 615 | $78.71 | |
| 11102 | <1% | 15 | $57.32 | |
| 82043 | <1% | 101 | $56.10 | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 45 | $55.78 |
| J8597 | Antiemetic drug, oral, not otherwise specified | <1% | 1,215 | $41.42 |
| G0008 | Administration of influenza virus vaccine | <1% | 114 | $21.78 |
| 90686 | <1% | 33 | $3.32 | |
| J7512 | Prednisone, immediate release or delayed release, oral, 1 mg | <1% | 17 | $0.90 |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | <1% | 15 | $0.24 |
| A9270 | Non-covered item or service | <1% | 93 | $0.06 |
| 97597 | 0% | 44 | $0.00 | |
| 0099U | 0% | 13 | $0.00 | |
| 93280 | 0% | 12 | $0.00 | |
| 20610 | 0% | 12 | $0.00 | |
| 93017 | 0% | 13 | $0.00 | |
| 90662 | 0% | 26 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialHUTCHENS, ALISHA (FMC PRESIDENT)
| Provider | Location | Paid |
|---|---|---|
| Forsyth Memorial Hospital, INC | Winston-salem, NC | $446K |
| Forsyth Memorial Hospital, INC. | Winston-salem, NC | $76K |
| Medical Park Hospital LLC | Winston-salem, NC | $58K |
| Forsyth Memorial Hospital, INC. | Winston-salem, NC | $11K |
| Medical Park Hospital LLC | Winston-salem, NC | $38.39 |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.